Astera Labs (NASDAQ:ALAB) Hits New 52-Week High – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as $271.32 and last traded at $271.5990, with a volume of 1891804 shares changing hands. The stock had previously closed at $244.26.

Analysts Set New Price Targets

Several analysts have commented on the company. TD Cowen upped their price objective on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Susquehanna increased their target price on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. UBS Group began coverage on Astera Labs in a research note on Tuesday, April 21st. They set a “neutral” rating and a $180.00 target price for the company. Morgan Stanley increased their target price on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Finally, Rothschild & Co Redburn began coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 target price for the company. Fifteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Trading Up 13.1%

The firm has a market capitalization of $47.33 billion, a PE ratio of 186.36, a P/E/G ratio of 2.85 and a beta of 3.35. The business has a 50 day moving average price of $159.81 and a 200-day moving average price of $157.14.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the prior year, the firm posted $0.33 EPS. The company’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Transactions at Astera Labs

In related news, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $117.47, for a total value of $1,174,700.00. Following the completion of the transaction, the general counsel directly owned 128,084 shares of the company’s stock, valued at $15,046,027.48. This trade represents a 7.24% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the sale, the chief executive officer owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,290,546 shares of company stock valued at $211,225,088. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds have recently made changes to their positions in the business. Nordea Investment Management AB purchased a new position in shares of Astera Labs in the 4th quarter worth $2,028,000. Geneva Partners LLC purchased a new position in shares of Astera Labs in the 3rd quarter worth $1,876,000. Numerai GP LLC raised its stake in shares of Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after acquiring an additional 7,992 shares during the period. Handelsbanken Fonder AB raised its stake in shares of Astera Labs by 289.5% in the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after acquiring an additional 93,800 shares during the period. Finally, Paragon Advisors LLC purchased a new position in shares of Astera Labs in the 3rd quarter valued at $1,829,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.